| # | Drug | Count |
|---|---|---|
| 0 | METRONIDAZOLE | 8 |
| 1 | PREDNISONE | 7 |
| 2 | RITUXIMAB | 7 |
| 3 | ADALIMUMAB | 6 |
| 4 | DEXAMETHASONE | 6 |
| 5 | DEXAMETHASONE 1.5 MG | 6 |
| 6 | LENALIDOMIDE | 6 |
| 7 | VEDOLIZUMAB | 6 |
| 8 | ALPRAZOLAM | 5 |
| 9 | ESZOPICLONE | 5 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | TAFASITAMAB-CXIX | 5 | 0.0055 |
| 1 | NITAZOXANIDE | 1 | 0.0029 |
| 2 | PALONOSETRON HYDROCHLORIDE | 3 | 0.0006 |
| 3 | ALBENDAZOLE | 1 | 0.0005 |
| 4 | DEFEROXAMINE MESYLATE | 1 | 0.0005 |
| 5 | RASBURICASE | 1 | 0.0004 |
| 6 | APREPITANT | 3 | 0.0004 |
| 7 | TREOSULFAN | 1 | 0.0004 |
| 8 | CLADRIBINE | 3 | 0.0003 |
| 9 | ANTI-THYMOCYTE GLOBULIN (RABBIT) | 2 | 0.0002 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Anthelmintic [EPC] | 1 | 0.0003 |
| 1 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 3 | 0.0003 |
| 2 | Nitroimidazole Antimicrobial [EPC] | 8 | 0.0001 |
| 3 | Antiprotozoal [EPC] | 1 | 0.0001 |
| 4 | Integrin Receptor Antagonist [EPC] | 6 | 0.0001 |
| 5 | CD52-directed Cytolytic Antibody [EPC] | 1 | 0.0001 |
| 6 | Purine Antimetabolite [EPC] | 5 | 0.0001 |
| 7 | Programmed Death Ligand-1 Blocker [EPC] | 1 | 0.0000 |
| 8 | Antimycobacterial [EPC] | 1 | 0.0000 |
| 9 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |